checkAd

     130  0 Kommentare Stoke Therapeutics Appoints Julie Anne Smith to its Board of Directors - Seite 3


    Business Wire (engl.)
    0 Follower
    Autor folgen
    Seite 3 von 3

    Stoke Therapeutics Appoints Julie Anne Smith to its Board of Directors - Seite 3 Stoke Therapeutics, Inc., (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced the appointment of Julie Anne Smith to its Board …